Expanded polytetrafluoroethylene mesh in chest-wall reconstruction: A 27-year experience

IF 4.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Thoracic and Cardiovascular Surgery Pub Date : 2025-01-01 DOI:10.1016/j.jtcvs.2024.05.026
Aida K. Sarcon MD , Omar A. Selim MBBCh, MS , Barbara L. Mullen MD , Benjamin F. Mundell MD, PhD , Steven L. Moran MD , K. Robert Shen MD
{"title":"Expanded polytetrafluoroethylene mesh in chest-wall reconstruction: A 27-year experience","authors":"Aida K. Sarcon MD ,&nbsp;Omar A. Selim MBBCh, MS ,&nbsp;Barbara L. Mullen MD ,&nbsp;Benjamin F. Mundell MD, PhD ,&nbsp;Steven L. Moran MD ,&nbsp;K. Robert Shen MD","doi":"10.1016/j.jtcvs.2024.05.026","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The study objective was to evaluate the success of expanded polytetrafluoroethylene mesh in chest-wall reconstruction.</div></div><div><h3>Methods</h3><div>We retrospectively reviewed patients who underwent expanded polytetrafluoroethylene (Gore-Tex) chest-wall reconstruction. The main outcome was a mesh-related event, defined as a mesh-related reoperation (eg, mesh infection requiring debridement with/without explant, tumor recurrence with explant) or structural dehiscence/mesh loosening with/without a hernia. Demographics and surgical outcomes were reported.</div></div><div><h3>Results</h3><div>A total of 246 reconstructions met inclusion (1994-2021). Fifty-five reconstructions (22.4%) had mesh-related events within a median of 1.08 years (interquartile range, 0.08-4.53) postoperatively; those without had a stable chest for a median of 3.9 years (interquartile range, 1.59-8.23, <em>P</em> &lt; .001). Forty-one meshes (16.6%) became infected, requiring reoperation. Eighty-eight percent (36/41) were completely explanted; 8.3% (3/36) required additional mesh placement. Predictors of mesh-related events were prior chest-wall radiation (odds ratio, 9.73, CI, 3.47-30.10, <em>P</em> &lt; .001), higher body mass index (odds ratio, 1.08, CI, 1.01-1.16, <em>P</em> = .019), and larger defects (odds ratio, 1.48, CI, 1.02-2.17, <em>P</em> = .042). The risk of mesh-related events with obesity was higher with prior chest-wall radiation.</div></div><div><h3>Conclusions</h3><div>Most patients (78%) with an expanded polytetrafluoroethylene mesh had a stable reconstruction after a median of 4 years. Obesity, larger defects, and prior chest-wall radiation were associated with a higher risk of a mesh-related event mostly due to mesh infections. Seventeen percent of reconstructions had reoperation for mesh infection; 88% were completely explanted. Only 8% required replacement mesh, suggesting that experienced surgeons can safely manage them without replacement. Future studies should compare various meshes for high-risk patients to help guide the optimal mesh selection.</div></div>","PeriodicalId":49975,"journal":{"name":"Journal of Thoracic and Cardiovascular Surgery","volume":"169 1","pages":"Pages 303-313.e2"},"PeriodicalIF":4.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic and Cardiovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022522324005129","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The study objective was to evaluate the success of expanded polytetrafluoroethylene mesh in chest-wall reconstruction.

Methods

We retrospectively reviewed patients who underwent expanded polytetrafluoroethylene (Gore-Tex) chest-wall reconstruction. The main outcome was a mesh-related event, defined as a mesh-related reoperation (eg, mesh infection requiring debridement with/without explant, tumor recurrence with explant) or structural dehiscence/mesh loosening with/without a hernia. Demographics and surgical outcomes were reported.

Results

A total of 246 reconstructions met inclusion (1994-2021). Fifty-five reconstructions (22.4%) had mesh-related events within a median of 1.08 years (interquartile range, 0.08-4.53) postoperatively; those without had a stable chest for a median of 3.9 years (interquartile range, 1.59-8.23, P < .001). Forty-one meshes (16.6%) became infected, requiring reoperation. Eighty-eight percent (36/41) were completely explanted; 8.3% (3/36) required additional mesh placement. Predictors of mesh-related events were prior chest-wall radiation (odds ratio, 9.73, CI, 3.47-30.10, P < .001), higher body mass index (odds ratio, 1.08, CI, 1.01-1.16, P = .019), and larger defects (odds ratio, 1.48, CI, 1.02-2.17, P = .042). The risk of mesh-related events with obesity was higher with prior chest-wall radiation.

Conclusions

Most patients (78%) with an expanded polytetrafluoroethylene mesh had a stable reconstruction after a median of 4 years. Obesity, larger defects, and prior chest-wall radiation were associated with a higher risk of a mesh-related event mostly due to mesh infections. Seventeen percent of reconstructions had reoperation for mesh infection; 88% were completely explanted. Only 8% required replacement mesh, suggesting that experienced surgeons can safely manage them without replacement. Future studies should compare various meshes for high-risk patients to help guide the optimal mesh selection.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
扩张聚四氟乙烯网在胸壁重建中的应用:27 年的经验
目的:评估膨体聚四氟乙烯(ePTFE)网片在胸壁重建中的成功率:评估膨体聚四氟乙烯(ePTFE)网片在胸壁重建中的成功率:我们对接受 ePTFE(Gore-Tex®)胸壁重建术的患者进行了回顾性研究。主要结果是与网片相关的事件,即与网片相关的再次手术(如需要清创的网片感染,带/不带外植体;肿瘤复发,带外植体)和/或结构性开裂/网片松动,带/不带疝气。结果:246 例重建符合纳入条件(1994-2021 年)。55例(22.4%)重建患者在术后中位 1.08 年(IQR 0.08,4.53)内发生过网片相关事件;未发生网片相关事件的患者在术后中位 3.9 年(IQR 1.59,8.23)内胸部情况稳定:大多数(78%)使用 ePTFE 网片的患者在中位 4 年后重建效果稳定。肥胖、缺损较大和曾接受过胸壁放射治疗的患者发生网片相关事件的风险较高,主要是由于网片感染。17%的重建手术因网片感染而再次手术;88%的重建手术完全拆除了网片。只有 8% 的患者需要更换网片,这表明经验丰富的外科医生可以安全地处理这些患者而无需更换网片。未来的研究应该对高风险患者使用的各种网片进行比较,以帮助指导最佳网片的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.20
自引率
10.00%
发文量
1079
审稿时长
68 days
期刊介绍: The Journal of Thoracic and Cardiovascular Surgery presents original, peer-reviewed articles on diseases of the heart, great vessels, lungs and thorax with emphasis on surgical interventions. An official publication of The American Association for Thoracic Surgery and The Western Thoracic Surgical Association, the Journal focuses on techniques and developments in acquired cardiac surgery, congenital cardiac repair, thoracic procedures, heart and lung transplantation, mechanical circulatory support and other procedures.
期刊最新文献
Donation after circulatory death versus donation after brain death longitudinal follow-up. Differential Prevalence and Prognostic Significance of Spread Through Air Spaces According to Oncogenic Driver Mutations in Lung Adenocarcinoma. Type A aortic dissection during pregnancy and postpartum: Experience in 60 patients over 25 years. More is Not Better: The Role of the Leukocyte Filter in Ex Vivo Lung Perfusion. Commentary: Setting the Bar: Defining Benchmarks in Open Thoracoabdominal Aortic Repair.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1